Press
If you would like to discuss anything press related, please email rarecan@ovidhealth.co.uk
RareCan in the News
Newcastle Chronicle – 5th October 2021 – Newcastle professor’s ‘matchmaking’ site helps patients with rare cancers find the clinical trials that could save their lives
Pharmafile – 25th August 2021 – RareCan appoints Dr Anita Cooper
Drug Discovery World – 4th August 2021 – Appointment strenghtens the experience of RareCan
RareCan appoints Dr Anita Cooper as Non-Executive Director
RareCan appoints Dr Anita Cooper as Non-Executive Director Hexham, UK, 2nd August 2021: RareCan, a new and innovative company accelerating research into rare cancers, today
Mandashi Invests in RareCan
Mandashi Invests in RareCan We urgently need to increase treatment options and improve outcomes for people with rare cancer. At RareCan, we are working with
RareCan and NovoPath Partnership
NovoPath & RareCan Partnership Analysing samples from tumours lies at the heart of the discovery of new forms of treatment for cancer. Rare Cancers are
PAWS GIST & GIST Cancer UK Partnership
PAWS GIST & GIST Cancer UK Partnership A couple of weeks ago we announced our collaboration with PAWS GIST and GIST Cancer UK. This collaboration,
